Higher consumption of linoleic acid and higher levels in the body may mitigate diabetes mellitus risk. The primary polyunsaturated fatty acid (PUFA) is linoleic acid (LA), an essential fatty acid that makes up 85 to 90% of PUFA dietary consumption in the US. PUFA’s are classified into n-9, n-6, and …

Young age at diagnosis or disease aggression which increases lifetime risk of CKD in type 2 patients with diabetes Type 2 Diabetes, once considered a disease that comes about at an older age, is now increasingly diagnosed in younger adults. The number of people between the ages of 20-39 years …

Metformin is used as first-line therapy but can also be used prophylactically. Almost three-quarters of women who experience gestational diabetes mellitus (GDM) will eventually develop type 2 diabetes (T2DM) in their lifetime. According to Whelan et al., “GDM is one of the most common complications of pregnancy affecting 6-8% of …

The association between anti-diabetic drug use and survival outcomes in patients on dialysis. Diabetic kidney disease that leads to end-stage renal disease (ESRD) and dialysis is common among patients with type 2 diabetes. However, the impact of anti-diabetic drugs on patients undergoing dialysis is rarely studied. Most patients with ESRD …

Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, improves cardiovascular events (MI, stroke, HF) in Type 2 Diabetes and Chronic Kidney Disease (CKD) patients.  Some risk factors for cardiovascular diseases (CVD), such as high blood glucose, blood pressure, serum cholesterol, and BMI, are also associated with CKD and type 2 diabetes. …

A new treatment is on its way providing superior results for the patients suffering from diabetic foot ulcers. Chronic diabetic foot ulcers (DFUs) account for around 80% of lower limb amputations, resulting in effective medical treatment and cost burdens. Currently, the treatment for DFUs concentrates mainly on local wound care, …

Patients with type 1 diabetes and eating disorders have a greater risk of diabetic ketoacidosis and all-cause mortality.  Eating disorders are severe illnesses associated with abnormal eating patterns secondary to pre-occupations with body weight and body image. Some examples of eating disorders include anorexia nervosa, bulimia nervosa, and binge eating …

Pharmacists in the community setting play a role in diabetes screening and management by providing direct patient care. With the constant increase in the prevalence of diabetes, education is vital in understanding how to control disease progression. Pharmacists play an essential role in disease management, assessing medication adherence, and educating …

Patients with diabetes are likely to be affected by Diabetic foot ulcers (DFUs). This type of disease is popular and enfeeble, generating a surge of serious morbidity and mortality combined with worldwide socio-economic problems. The symptoms of this disease such as infection and inflammation raise surrounding oedema of the foot. …

Liraglutide to positively effect decrease in visceral fat in overweight and obese patients without history of type 2 diabetes. Critical drivers of adverse cardiometabolic outcomes in obese patients are visceral and ectopic fat, which is wrapped around the abdominal organs in the body. This type of fat can lead to …